ERYTECH PHARMA - SPON ADR (ERYP) Stock Analyst Ratings

NASDAQ:ERYP • US29604W1080

0.78 USD
0 (0%)
Last: Jun 28, 2023, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

42

ChartMill assigns a Buy % Consensus number of 42% to ERYP. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 3.94. This target is 405.11% above the current price.
  • ERYP was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about ERYP.
  • In the previous month the buy percentage consensus was at a similar level.
  • ERYP was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
ERYP Historical Analyst RatingsERYP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.783.903.943.944.06 - 400.16% 405.11% 405.11% 419.97%

Related screens

Find peers 30% below price target
ERYP Current Analyst RatingERYP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades

ERYTECH PHARMA - SPON ADR / ERYP FAQ

What is the average price target for ERYTECH PHARMA - SPON ADR (ERYP) stock?

9 analysts have analysed ERYP and the average price target is 3.94 USD. This implies a price increase of 405.11% is expected in the next year compared to the current price of 0.78.


What is the consensus rating for ERYP stock?

The consensus rating for ERYTECH PHARMA - SPON ADR (ERYP) is 42.2222 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


What is the number of analysts for ERYP stock?

The number of analysts covering ERYTECH PHARMA - SPON ADR (ERYP) is 9.